Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more AC Immune Charts.

AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more AC Immune Charts.

AC Immune SA News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 13 March 2025 (6 hours ago) • Edgar (US Regulatory)

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Thursday 13 March 2025 (6 hours ago) • Edgar (US Regulatory)

AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update
Thursday 13 March 2025 (6 hours ago) • GlobeNewswire Inc.

AC Immune to Participate in Upcoming Investor Conferences
Tuesday 4 March 2025 (1 week ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 18 December 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 13 December 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 10 December 2024 (3 months ago) • Edgar (US Regulatory)

AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome
Tuesday 10 December 2024 (3 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 14 November 2024 (4 months ago) • Edgar (US Regulatory)

AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
Thursday 14 November 2024 (4 months ago) • GlobeNewswire Inc.

AC Immune to Present at the Jefferies 2024 London Healthcare Conference
Wednesday 13 November 2024 (4 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 5 November 2024 (4 months ago) • Edgar (US Regulatory)

More AC Immune SA News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions